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ABSTRACT
Helicobacter pylori, a gram negative microaerophilic bacterium, is known to cause gastritis, peptic ulcer disease, and
gastric adenocarcinoma. An extragastric reservoir of this bacterium can cause recurrent infection in treated patients.
The oral cavity is considered an important extragastric reservoir owing to the favorable milieu in subgingival areas
and the symbiotic association between H. pylori and Candida, a common commensal organism in the oral cavity.
Objectives: To evaluate the presence of H. pylori and Candida in the saliva of patients with chronic gastritis.
Methods: The study comprised subjects with H. pylori-positive gastritis (Group I n = 30), subjects with H. pyolori
negative gastritis (Group II, n = 30) and normal controls without gastritis (Group III, n = 10). Unstimulated saliva
(whole mouth fluid) samples were collected and subjected to real-time polymerase chain reaction analysis for
detecting the Urease A gene of H. pylori. Sabouraud’s dextrose agar was used to detect the presence of Candida
species. Results: Overall, 7 (23.3%) and 4 (13.3%) patients from Group I and Group II, respectively, were positive
for oral H. Pylori, whereas 14 (46.6%) and 8 (26.6%) patients from Group I and Group II, respectively, exhibited
oral Candida. Four patients (13.3%) from Group I exhibited both oral H. pylori and Candida. Conclusion: H. pylori
and Candida in the oral cavity could potentially influence H. pylori recolonization of the gastric mucosa leading
to recurrent gastritis.
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INTRODUCTION

The natural niche of H. pylori is the gastric mucosa;
however, extragastric sites, such as the oral cavity and
esophgaus,7-12 may harbor this bacterium. In the oral
cavity, H. pylori is commonly detected in the dental
plaque,13,14 particularly surrounding the molar teeth.13
Moreover, H. pylori has been isolated from the tonsils,
adenoids,15 and fingernails.12 H. pylori is transmitted
from person to person and colonizes the gastric
mucosa. The persistence of H. pylori and resistance to
treatment is attributed to the versatile adaptability of
this organism via mutations and genetic recombinations
between strains as well as via its ability to evade host
immunity.16 Moreover, the persistence of this organism
has been attributed to its presence in ecologically
protected niches, such as the vacuoles of host immune
cellsand epithelial cells and within Candida.17 Candida
is a ubiquitous fungi present in 40%–60% of healthy
human oral cavities. Nonculturable bacterium-like
bodies (BLBs) of H. pylori have been detected within

Helicobacter pylori is a gram-negative microaerophilic,
spiral bacterium measuring 2.5–5 µ in length. The
organism has adapted to survive in the gastric mucosa.
It contains f lagella for facilitating motility in the
viscous mucous lining of the stomach. The enzyme
urease produced by the bacteria safeguards it against
the gastric acidity and adhesin helps it to firmly bind
to the mucosa. H. pylori infection can cause focal or
multifocal atrophic or nonatrophic gastritis, peptic
ulcer disease, noncardia gastric carcinoma, and
lymphoma.1,2 H. pylori has been designated as a Group
I carcinogen by the International Agency for Research
on Cancer of the World Health Organization.3 Besides
gastric mucosal diseases, H. pylori infection has been
associated with other conditions including recurrent
aphthous stomatitis,4 dyslipidemias,5 and coronary
atherosclerosis.6
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the vacuoles of Candida in the oral cavity and upper
gastrointestinal tract of patients with peptic ulcer.19
H. pylori and Candida have a symbiotic relationship,
which may have a role in the persistence of H. pylori
within the oral cavity and gastric mucosa as well as in
recurrent H. pylori infection.17
Numerous tests are available to detect H. pylori, such
as the histopathological analysis of endoscopic biopsies,
culture, Urea Breath Test (UBT), Rapid Urease test
(RUT), enzyme immunoassay, Southern Blot, and
polymerase chain reaction (PCR) of H. pylori genes,
such as the cytotoxin vacuolating gene Vac A s1 s2,19
16 S rRNA,8,11,14,18 Urease A,9,10 and Urease AB.19
The present study was conducted to assess the presence
of H. pylori and Candida in the oral cavity of patients
with symptomatic gastritis.

Figure 1: Amplification plot showing the positive samples
crossing the threshold fluoresence. Samples crossing the
threshold fluorescence are considered positive for H. pylori.

METHODS

ratio of A260:A230 was performed to measure the
contamination of phenolate ions, thiocyanates, and
other organic compounds. All samples exhibited an
A260:A230 ratio of >1.5 and A260:A280 ratio of >2.0.
The minimum yield of DNA required for amplification
was 4 ng/µL. PCR was performed using the genomic
DNA isolated from the saliva to detect the presence
of Urease A. PCR amplification was performed in
a total volume of 25 µL PCR assay using 12.5 µL
Master Mix (Qiagen, Hilden, Germany), 4 µL Primer
and Probe for Urease A, 5 µL template DNA, and 3.5
µL Millipore water. The recruited primers were as
follows: Forward Sequence, GGC AAA AAA GCC
GTT AGC GTG AA; Reverse Sequence, TGT CCC
GCT CGC AAT GTC TAA G; and Probe Sequence,
TTGGCGACAGACCGGTTCAAATCGGCTCACAC.
The PCR assay was transferred into Eppendorf PCR
cuvettes and the cuvettes were centrifuged for 5 s
and then transferred into Eppendorf Master Cycler ®
to perform real-time PCR. PCR amplification was
programmed as follows: initial denaturation at 95°C
for 15 min, followed by 40 cycles with a standard
cycle containing denaturation at 95°C for 15 s followed
by annealing and extension at 60°C for 1 min. The
threshold line for the detection of fluorescence was
fixed at 257 based on normalized data, and 40 cycles
was set as the maximum. Samples crossing the
fluorescence threshold line were considered positive
and their cycle threshold (Ct) value was recorded
(Figure 1).

A total of 60 patients attending a gastroenterology unit
for the endoscopic investigation of gastritis as well
as the signs and symptoms of dyspepsia (complaints
of abdominal pain, belching, retrosternal pain, and
bloating), who were not undergoing any antifungal
or proton pump inhibitor therapy, were included in
the study. Moreover, 10 asymptomatic individuals
without any history of gastritis or receiving any
medication, who attended Ragas Dental College and
Hospital, Chennai, for routine dental treatment, were
included as controls. Based on endoscopic findings,
the study participants were classified, as those with
H. pylori-positive gastritis (Group I, n = 30), those
with H. pylori-negative gastritis (Group II, n = 30),
and the asymptomatic controls without gastritis and
not undergoing any therapy (Group III, n = 10). A
thorough history and physical examination findings
were recorded in a preformatted questionnaire. Ethical
permission was obtained from the Institutional Review
Board of Ragas Dental College and Hospital, Chennai.
Informed consent was obtained from the participants
before enrollment in the study. Unstimulated saliva was
obtained using the spit technique.8 The participants
were instructed to spit (unstimulated) saliva into a
50 mL sterile container every minute for 10 minutes
and the containers were stored in the deep freezer at
−70ºC at Ragas Dental College. The saliva sample of
each patient was divided into two parts—one for PCR
analysis and the other for Candida culture. DNA from
the saliva samples was extracted by standard extraction
protocol using the HiYield Genomic DNA Minikit –
Real Genomics™ (Real Biotech Corporation, Taipei,
Taiwan). Following DNA extraction, the DNA was
quantified using spectrometric analysis to confirm
the yield by monitoring the absorption (A) of UV
light at various wavelengths—280, 260, and 230 nm.
An absorption ratio at A260:A280 was performed to
measure the contamination of proteins. An absorption

For identifying the presence of Candida, the saliva
collected in the sterile container was sampled using a
sterile 0.001 µL loop and inoculated by streaking on
Sabouraud’s Dextrose Agar (HIMEDIA™, Mumbai,
India) supplemented with chloramphenicol (10 mg/
mL) and incubated at 37°C for 48 h. After 48 h, the
growth of white, creamy, smooth, raised Candida
colonies along the line of streaking was recorded as
a positive growth and the subject was considered as
27
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Group I, 8 in Group II, and 3 in Group III (P = 0.5).
(Table 3).
Significant correlation was not observed between the
presence of gastric versus salivary H. pylori (N = 60, r
= 0.129, p= 0.3), salivary H. pylori versus oral Candida
(N = 60, r = 0.003, p= 0.9), and gastric H. pylori versus
oral Candida (N = 60, r = 0.208, p=0.1). No correlation
was observed between overall age and candidal status
of the saliva in patients with symptomatic gastritis (p=
0.64). On comparing the candidal status between the
age groups in participants <30 years old, the OR was
7.5 (95% CI, 0.98–68.75, p= 0.035, Table 2. There was
no significant difference in the mean CFU/mL between
Groups I and II. Patients with gastritis exhibiting H.
pylori and Candida in the saliva showed a mean CFU
of 5250 ± 3095.69. Patients who were positive for oral
Candida and H. pylori in the gastric mucosa exhibited
a 8.22 times higher risk of having symptomatic gastritis
than those who did not have oral Candida (95%
CI, 1.1–61.495, p= 0.038) (Table 4). The correlation
coefficient between age and salivary candidal positivity
was significant (−0.296; p= 0.022*; Table 2).

Figure 2: Candidal colonies formed in Sabouraud dextrose
agar medium after 48 h of incubation at 37oC.

a Candida carrier. The colony-forming units (CFU)
were manually counted by multiplying the number
of individual colonies by a factor of 1000, which was
represented as CFU/mL (CFU/mL = No of colonies in
a SDA plate × 1000) (Figure 2).
Statistical analysis
Statistical analysis was performed using SPSS™ version
11.0.1 (SPSS, Inc., Chicago, IL, USA). The χ2 test was
conducted to determine the age and sex distribution
between the groups. Spearman correlation coefficient
was used to assess the relationship between age, gastric
and salivary H. pylori, and salivary Candida. Pearson
χ2 test was used to study the association between the
salivary and gastric H. pylori and salivary Candida.
Odds ratio (OR) and 95% confidence interval (CI) were
estimated to study the association of salivary H. pylori
and salivary Candida in the patients with gastritis. P <
0.05 was considered significant.

DISCUSSION
H. pylori as a causative agent for gastritis was first
documented by Marshal and Warren in 1983.1 The
bacterium causes progressive damage to the gastric
mucosa due to chronic inflammation, and over a period
of time, it leads to gastric adenocarcinoma or gastric
mucosa-associated lymphoid tissue lymphoma. 20
Chronic H. pylori infection affects approximately twothirds of the population worldwide and has a prevalence
of approximately 90% in developing countries. Low
education levels and low socioeconomic status are
associated with an increase in the prevalence of H.
pylori infection.21 Epidemiological data shows that the
rate at which a population acquires H. pylori infections
is higher in developing than in developed countries.22
The presence of H. pylori in the oral cavity has been
reported by various researchers, who have suggested
that its presence acts as a primary extragastric reservoir
that can contribute to gastric reinfection following
eradication therapy as well as have an active role in
person-to-person transmission.9,10 However, some
studies have reported the absence of any evidence for
the oral cavity as a major reservoir for H. pylori.7,23 This
could be attributed to the difficulty in sample collection
because the bacteria is found in specialized niches in
the oral cavity, such as in plaques rather than in saliva.
Anand et al.,24 in their review of the literature on the
presence of H. pylori in the oral cavity, have found that
in patients with H. pylori infection, the detection of H.
pylori in the dental plaque is higher than that from the
saliva because plaque acts as a biofilm that facilitates
the adherence of the bacteria to the solid surfaces.24

RESULTS
Overall, there were 23 males and 7 females in Group I
(H. pylori-positive gastritis; 6 of these participants were
<30 and 24 were >30 years old), 24 males and 6 females
in Group II (H. pylori-negative gastritis; 3 of these
participants were <30 and 27 were >30 years old), and 5
males and 5 females in Group III (8 of these participants
were <30 and 2 were >30 years old. (Table 1).
Of the 60 patients with symptomatic gastritis, 11
(36.6%) exhibited H. pylori in the saliva [7/30 (23.3%)
in Group I and 4/30 (13.3%) in Group 2; p=0.5]. No
subject in Group III exhibited H. pylori in the saliva.
The OR for gastritis and salivary H. pylori was 1.98
(p= 0.05; 95% CI, 0.51–7.61). (Table 2)
Oral Candida was isolated from 22 patients with
gastritis and from 3 participants in the control group.
On comparison between the subjects in various groups,
Candida occurred in the saliva in 14 participants in
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Table 1. Age and Sex Distribution between the Study Groups (N = 70)
Group I

Group II

Age Groups Male

Female

Group III

Male

Female

Male

Female

N

%

N

%

N

%

N

%

N

%

N

%

≤30

6

26.1

-

-

3

12.5

-

-

3

60

5

100

31–50

13

56.5

5

71.4

10

41.7

4

66.7

2

40

-

-

>50

4

17.4

2

28.6

11

45.8

2

33.3

-

-

-

-

Total

23

76.7

7

23.3

24

80

6

20

5

50

5

50

P value

0.307

0.450

0.444

Table 2. Relation between Age and Salivary Candidal Status in Patients with Symptomatic Gastritis (N = 60)
Age Group

Candida in the Saliva

OR

95% CI

p value^

3 (33.3%)

7.5

0.98–68.75

0.035*

12 (37.5%)

20 (62.5%)

2.25

0.52–10.37

0.36

4 (21.1%)

15 (78.9%)

Present

Absent

<30

6 (66.7%)

30–50 *
>50

p value

0.064

Pearson χ between the age and salivary candidal status (P = 0.064). CI, Confidence interval; OR, Odds ratio; *=reference
2

Table 3. Presence of Salivary H. pylori and Salivary Candida in Various Groups
Salivary H. pylori

Group I

Group II

Candida

Group III

Candida

Candida

Present

Absent

Present

Absent

Present

Absent

Positive

4

3

0

4

0

0

Negative

10

13

8

18

3

7

30

30

10

Table 4. Salivary Candida and Salivary Helicobacter Pylori in the Oral Cavity
Status of oral
Candida and H. Pylori

Symptomatic Gastritis
H. pylori-positive
(n = 30)

H. pylori-negative
(n = 30)

Positive

4 (13.3%)

0

Negative*

26 (86.7%)

30 (100%)

30

30

OR

95% CI

P value

8.22

1.1–61.495

0.038*

CI, Confidence interval; OR, Odds ratio; *= as reference

techniques show better sensitivity. We used real-time
PCR (using Urease A) to detect H. pylori in the saliva.
Moreover, it has been shown that in patients who
received systemic drug therapy for the eradication
of H. pylori in the stomach, oral H. pylori was not
eliminated. However, in patients who had concurrently
used antiplaque mouth rinses alone or in combination
with periodontal treatment, considerable reduction in
the prevalence of oral H. pylori was observed, along
with better eradication rates for gastric H. pylori.25
In our study, the patients did not use any mouthwash
before sample collection.

The most commonly used method for the detection of
H. pylori in the gastric mucosa is endoscopic biopsy
and Giemsa staining; immunohistochemical analysis
is also used. Other methods include the RUT, culture,
serology, and UBT to diagnose or monitor the presence
of H. pylori.18 In our study, we used Giemsa-stained
histological section to detect H. pylori in the gastric
mucosa.
At sites where the bacteria is present in lower levels,
such as gastric secretions, saliva, and stools, PCR
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that a symbiotic relationship exists between Candida
and H. pylori in the oral cavity, which facilitates the
H. pylori gastric reinfection.19

Candida albicans is the yeast species more often
isolated from various sites in healthy adults, children,
and hospitalized patients. The oral Candida carriage
rate in normal healthy children can be as high as
75% of the study group.26 Candida species are highly
complex group of micro-organisms with a remarkable
ability to adapt to environmental stress exposure to
antimicrobials and to the host immune system as well as
to changes in host physiology.27,28 C. albicans have been
found to colonize various human body surfaces, such
as the oral cavity, genitourinary tract, gastrointestinal
tract, and skin.28,29 Although, yeast and bacteria have
coexisted for years, the biological interaction between
them remains predominantly unknown. An association
between H. pylori and Candida was first documented by
Siavoshi et al.,30 who proposed that the H. pylori BLBs
were observed within the vacuoles of the Candida as
an adaptation for invasion, and subsequently, for its
persistence and survival. They further proposed that
the association between the bacterium and yeast serves
to protect H. pylori from environmental stress.30

Our findings showed that salivary H. pylori is an
extragastric reservoir and indicated that it has a
potential role in primary infection and reinfection in
gastritis. The synergistic role of oral Candida with H.
pylori is being increasingly recognized and further
longitudinal studies are required to understand and for
improving the management of gastritis.

CONCLUSION
This study found the presence of H. pylori and Candida
in the saliva of patients with chronic gastritis, showing
extragastric reservoir. H. pylori and Candida in
the oral cavity could potentially influence H. pylori
recolonization of the gastric mucosa leading to
recurrent gastritis.

The presence of Candida in patients with gastritis, even
in low levels, may cause injury to the epithelium due to
the action of proteolytic enzymes secreted by the fungal
blast conidia or spores.31 The coexistence of Candida
and H. pylori in the gastric mucosa of these patients
exhibits a synergistic effect in the pathogenesis of the
inflammation.32 An intracellular symbiotic relationship
between H. pylori and Candida has been proposed as
an important mechanism for the survival of H. pylori
outside its well-known niche, the human stomach.19,21
We observed that patients with symptomatic gastritis
aged <30 years old exhibited 7.5 (OR) times (P =
0.035) higher chance of having oral Candida than
those who were aged >50 years old and this association
was significant (P = 0.064). As the age increased, the
mean CFU/mL increased in the overall study group.
This finding could be attributed to the fact that older
individuals have other local and systemic factors that
could influence and provide a suitable environment
for the growth of Candida.33 Moreover, in our study,
the prevalence of H. pylori infection was lower in the
younger age group (20–39 years) and higher in the older
age group (40–59 years).
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